467 related articles for article (PubMed ID: 32446698)
1. Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study.
Freedberg DE; Conigliaro J; Wang TC; Tracey KJ; Callahan MV; Abrams JA;
Gastroenterology; 2020 Sep; 159(3):1129-1131.e3. PubMed ID: 32446698
[No Abstract] [Full Text] [Related]
2. Famotidine Against SARS-CoV2: A Hope or Hype?
Ghosh R; Chatterjee S; Dubey S; Lavie CJ
Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
[No Abstract] [Full Text] [Related]
3. Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.
Mather JF; Seip RL; McKay RG
Am J Gastroenterol; 2020 Oct; 115(10):1617-1623. PubMed ID: 32852338
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Samimagham HR; Hassani Azad M; Haddad M; Arabi M; Hooshyar D; KazemiJahromi M
Trials; 2020 Oct; 21(1):848. PubMed ID: 33050945
[TBL] [Abstract][Full Text] [Related]
5. Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
Hogan Ii RB; Hogan Iii RB; Cannon T; Rappai M; Studdard J; Paul D; Dooley TP
Pulm Pharmacol Ther; 2020 Aug; 63():101942. PubMed ID: 32871242
[TBL] [Abstract][Full Text] [Related]
6. Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series.
Janowitz T; Gablenz E; Pattinson D; Wang TC; Conigliaro J; Tracey K; Tuveson D
Gut; 2020 Sep; 69(9):1592-1597. PubMed ID: 32499303
[TBL] [Abstract][Full Text] [Related]
7. BET 1: Lopinavir-ritonavir and COVID-19.
Dolan D; Ingham J; Baombe J
Emerg Med J; 2020 Jul; 37(7):450-451. PubMed ID: 32616658
[No Abstract] [Full Text] [Related]
8. Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
Greco A; Buccheri S; D'Arrigo P; Calderone D; Agnello F; Monte M; Milluzzo RP; Franchina AG; Ingala S; Capodanno D
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):335-337. PubMed ID: 32671399
[No Abstract] [Full Text] [Related]
9. Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review.
Chenchula S; Ray A; Sadasivam B
Drug Res (Stuttg); 2021 Jul; 71(6):295-301. PubMed ID: 33757133
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
11. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G
J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278
[TBL] [Abstract][Full Text] [Related]
12. 2020 - Year of COVID-19.
Lillicrap D; Morrissey JH
J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
[No Abstract] [Full Text] [Related]
13. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
van de Veerdonk FL; Kouijzer IJE; de Nooijer AH; van der Hoeven HG; Maas C; Netea MG; Brüggemann RJM
JAMA Netw Open; 2020 Aug; 3(8):e2017708. PubMed ID: 32789513
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
15. BET 2: Hydroxychloroquine in the treatment of COVID-19.
Howard L; Baombe J; Reynard C
Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
[No Abstract] [Full Text] [Related]
16. Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence.
Ma T; Wu M
Am J Gastroenterol; 2021 Apr; 116(4):848-849. PubMed ID: 33982973
[No Abstract] [Full Text] [Related]
17. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
Zhu L; Gong N; Liu B; Lu X; Chen D; Chen S; Shu H; Ma K; Xu X; Guo Z; Lu E; Chen D; Ge Q; Cai J; Jiang J; Wei L; Zhang W; Chen G; Chen Z
Eur Urol; 2020 Jun; 77(6):748-754. PubMed ID: 32317180
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone nanomedicines for COVID-19.
Lammers T; Sofias AM; van der Meel R; Schiffelers R; Storm G; Tacke F; Koschmieder S; Brümmendorf TH; Kiessling F; Metselaar JM
Nat Nanotechnol; 2020 Aug; 15(8):622-624. PubMed ID: 32747742
[No Abstract] [Full Text] [Related]
19. What Is COVID-19?
Wiersinga WJ; Prescott HC
JAMA; 2020 Aug; 324(8):816. PubMed ID: 32648917
[No Abstract] [Full Text] [Related]
20. Angioedema, ACE inhibitor and COVID-19.
Grewal E; Sutarjono B; Mohammed I
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32912894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
